Angel Biotechnology Holdings has confirmed a joint venture with Materia Medica Holding (MMH) should be completed before the end of the year.
The deal was first mooted in October last year and involves the joint company operating from a dedicated manufacturing site at Angel's facility in Cramlington, Northumberland.
Russian firm MMH is a long-time customer of Angel's and uses the Scottish firm, which has a site at the Pentlands Science Park near Edinburgh, for biomaterial manufacturing.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
